{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/insurance-and-indemnity-requirements”
},
“@id”: “https://www.clinicalstudies.in/insurance-and-indemnity-requirements”,
“headline”: “SOP for Insurance and Indemnity Requirements”,
“name”: “SOP for Insurance and Indemnity Requirements”,
“description”: “Comprehensive SOP defining insurance and indemnity requirements for clinical trials under TGA oversight, including sponsor responsibilities, site obligations, and compliance with GCP.”,
“keywords”: “insurance requirements clinical trials, indemnity SOP Australia, CTN CTX insurance compliance, trial indemnity requirements TGA, investigator indemnity SOP, site insurance SOP, sponsor insurance obligations Australia, indemnity agreement SOP, TGA trial governance, site indemnity documentation, ethics approval insurance requirements, clinical trial insurance checklist, sponsor indemnification responsibilities, Australian trial insurance SOP, SSA insurance requirements, trial governance indemnity, site indemnity verification SOP, indemnity certificate SOP Australia, insurance policy documentation SOP, subject insurance requirements, insurance compliance Australia, indemnity in CTN CTX schemes, ethics indemnity approval, SOP for indemnity records, trial sponsor insurance QA SOP”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}
Published on 22/12/2025
Insurance and Indemnity Requirements SOP
| Department | Clinical Research |
|---|---|
| SOP No. | CS/TGA-INS/176/2025 |
| Supersedes | N.A. |
| Page No. | 1 of 20 |
| Issue Date | 28/08/2025 |
| Effective Date | 05/09/2025 |
| Review Date | 05/09/2027 |
Purpose
The purpose of this SOP is to establish requirements for insurance and indemnity in clinical trials conducted under the CTN/CTX schemes in Australia. It ensures sponsor, site, and investigator compliance with TGA, Human Research Ethics Committee (HREC), and institutional governance requirements to safeguard participant rights and provide indemnity coverage for clinical trial-related injuries.
Scope
This SOP applies to all clinical trials sponsored or managed by the organization in Australia requiring insurance and indemnity arrangements. It covers sponsor obligations for trial insurance, indemnity agreements with investigators and sites, documentation requirements, and institutional governance compliance. It also applies to multi-site trials requiring SSA documentation of insurance arrangements.
Responsibilities
- Sponsor: Secures insurance policy covering trial participants for injury or harm related to investigational products and trial procedures.
- Principal Investigator (PI): Ensures site staff are informed of indemnity arrangements and provides indemnity certificates to site governance offices.
- Regulatory Affairs (RA): Confirms insurance documents are filed with CTN/CTX submissions and SSA applications.
- Clinical Project Manager (CPM): Coordinates insurance certificates for each site and maintains tracking logs.
- Quality Assurance (QA): Audits insurance and indemnity records for inspection readiness.
Accountability
The Sponsor is accountable for ensuring valid insurance and indemnity coverage throughout the trial duration. The Head of Clinical Research is accountable for maintaining oversight of insurance arrangements across all trials.
Procedure
1. Insurance Policy Requirements
- Obtain trial insurance policy covering clinical trial liability, participant compensation, and investigator indemnity.
- Ensure policy meets Australian law and HREC requirements.
- Maintain policy validity throughout the study with no lapses in coverage.
2. Indemnity Agreements
- Prepare indemnity agreements for investigators and institutions using Medicines Australia Standard Indemnity templates.
- Ensure indemnity agreements are executed before trial initiation at each site.
- File signed agreements in TMF and ISF.
3. Documentation for Ethics and Governance
- Submit copies of insurance policies and indemnity agreements with HREC and SSA applications.
- Record acknowledgments and approvals in Insurance Documentation Log.
4. Monitoring and Renewals
- Monitor policy expiry dates and renew coverage before lapse.
- Update insurance certificates for protocol amendments or trial extensions.
5. Archiving
- Archive insurance and indemnity documents for a minimum of 15 years or as per institutional requirements.
Abbreviations
- CTN: Clinical Trial Notification
- CTX: Clinical Trial Exemption
- TGA: Therapeutic Goods Administration
- HREC: Human Research Ethics Committee
- SSA: Site-Specific Assessment
- PI: Principal Investigator
- CPM: Clinical Project Manager
- RA: Regulatory Affairs
- QA: Quality Assurance
- TMF: Trial Master File
- ISF: Investigator Site File
Documents
- Insurance Documentation Log (Annexure-1)
- Indemnity Agreement Template (Annexure-2)
- Insurance Certificate Tracker (Annexure-3)
References
- TGA — Clinical Trials Guidance
- Medicines Australia Standard Indemnity
- ICH E6(R2) Good Clinical Practice
Version: 1.0
Approval
| Prepared By | Checked By | Approved By |
|---|---|---|
| Name: Rajesh Kumar Date: 20/08/2025 Signature: __________ |
Name: Sunita Reddy Date: 22/08/2025 Signature: __________ |
Name: Dr. Meera Iyer Date: 28/08/2025 Signature: __________ |
Annexures
Annexure-1: Insurance Documentation Log
| Date | Policy No. | Coverage Type | Expiry Date | Status | Owner |
|---|---|---|---|---|---|
| 05/08/2025 | POL-2025-01 | Clinical Trial Liability | 05/08/2026 | Active | Rajesh Kumar |
Annexure-2: Indemnity Agreement Template
| Institution | Investigator | Agreement Type | Date Signed |
|---|---|---|---|
| Melbourne General Hospital | Dr. Sarah Lee | Medicines Australia Standard Indemnity | 10/08/2025 |
Annexure-3: Insurance Certificate Tracker
| Site | Certificate No. | Issued Date | Expiry Date | Status |
|---|---|---|---|---|
| Sydney Clinical Centre | IC-2025-07 | 12/08/2025 | 12/08/2026 | Valid |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 28/08/2025 | 1.0 | Initial SOP for insurance and indemnity requirements. | New SOP created for compliance with TGA CTN/CTX governance. | Head of Clinical Research |
For more SOPs visit: Pharma SOP.
